Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Riad Taher"'
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-5 (2021)
Abstract Background Euglycemic diabetic ketoacidosis is an uncommon but life-threatening complication associated with the use of sodium-glucose cotransporter 2 inhibitors that causes lower than expected blood glucose levels typically seen in diabetic
Externí odkaz:
https://doaj.org/article/48a3daf221024752bc36f753432098c4
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background Patients with type 2 diabetes mellitus are at an increased risk of adverse cardiovascular events compared to those without diabetes. The timing, relative to disease onset, and degree of glycemic control that reduces the risk of ad
Externí odkaz:
https://doaj.org/article/44af5cb624c242c3974968039b9c0d5a
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 30, Iss , Pp 100584- (2020)
Background: ACC/AHA guidelines recognize the progressive nature of heart failure (HF). Patients with risk factors (Stage A) are at risk for developing asymptomatic cardiac dysfunction (Stage B), which may then lead to symptomatic HF (Stage C). As suc
Externí odkaz:
https://doaj.org/article/23be8819800d4ca19ecad0a805b5ee06
Autor:
Takumi Toya, Jaskanwal D. Sara, Ben Lerman, Ali Ahmad, Riad Taher, Shigeo Godo, Michel T. Corban, Lilach O. Lerman, Amir Lerman
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 28, Iss , Pp 100515- (2020)
Background: Hyperhomocysteinemia (HHcy) has been proposed as an important cardiovascular risk factor (cRF). However, little is known about the association between plasma homocysteine levels and peripheral microvascular endothelial dysfunction (PMED),
Externí odkaz:
https://doaj.org/article/114d406e0c584e8b89079c076e28ca04
Autor:
Takumi Toya, Jaskanwal D. Sara, Ali Ahmad, Valentina Nardi, Riad Taher, Lilach O. Lerman, Amir Lerman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 9 (2020)
Background Peripheral microvascular endothelial dysfunction (PMED) has been linked to an increased risk of cardiovascular events, but there is a lack of information characterizing the predictive value of PMED for future risk of ischemic stroke (IS).
Externí odkaz:
https://doaj.org/article/77b73453b58c4b6285fc50c107730cb8
Publikováno v:
European Cardiology Review, Vol 15, Iss , Pp - (2020)
Heart failure is a common debilitating illness, associated with significant morbidity and mortality, rehospitalisation and societal costs. Current guidelines and position statements emphasise the management of patients with overt symptomatic disease,
Externí odkaz:
https://doaj.org/article/9d31135db4f84f16a8f9500e52e9cb78
Autor:
Rabea Asleh, Hilmi Alnsasra, Richard C. Daly, Sarah D. Schettle, Alexandros Briasoulis, Riad Taher, Shannon M. Dunlay, John M. Stulak, Atta Behfar, Naveen L. Pereira, Robert P. Frantz, Brooks S. Edwards, Alfredo L. Clavell, Sudhir S. Kushwaha
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 22 (2019)
Background The presence of a durable left ventricular assist device (LVAD) is associated with increased risk of vasoplegia in the early postoperative period following heart transplantation (HT). However, preoperative predictors of vasoplegia and its
Externí odkaz:
https://doaj.org/article/812f74e0dbcd4b8bb8450566ba730414
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 12:1035-1045
Purpose: Metabolic syndrome (MetS) and peripheral endothelial dysfunction (PED) are both independently associated with an increased risk of cardiovascular disease (CVD). PED provides prognostic information beyond that provided by conventional risk fa
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)
Cardiovascular Diabetology
Cardiovascular Diabetology
Background Patients with type 2 diabetes mellitus are at an increased risk of adverse cardiovascular events compared to those without diabetes. The timing, relative to disease onset, and degree of glycemic control that reduces the risk of adverse car
Publikováno v:
Circulation. 142
Introduction: Previous studies in patients with Raynaud’s phenomenon (RP) have found an association between microvascular abnormalities assessed via nail fold capillaroscopy as well as macrovascular peripheral endothelial dysfunction (PED). However